A systematic review of pregnancy exposure registries: examination of protocol-specified pregnancy outcomes, target sample size, and comparator selection
Kate Gelperin(United States Food and Drug Administration), Leyla Şahin, Lockwood G. Taylor(United States Food and Drug Administration), Kira Leishear(United States Food and Drug Administration), Steven T. Bird(United States Food and Drug Administration), Christian Hampp(Center for Drug Evaluation and Research), Hoda T. Hammad(Center for Drug Evaluation and Research)
Cited by 50
Related Papers
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers
|American Journal of Obstetrics and Gynecology|2013|118
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93
Risk of acute kidney injury associated with the use of fluoroquinolones
|Canadian Medical Association Journal|2013|89